14-day Premium Trial Subscription Try For FreeTry Free

Breakout Stocks of Week 44

NASDAQ was up last week (week 43) by 1.29% ending at 15,090.20 points after gaining 192.86 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Signet Jewelers Limited NYSE:SIG. This stock has had a buy signal since Sep 13, 2021 when the price was $76.83 and is so far up 17.23% to $90.07. Some other companies are on our watchlist to, among these are Veoneer Inc. NYSE:VNE Sutro Biopharma Inc. NASDAQ:STRO Telos Corp NASDAQ:TLS and Lumentum Holdings Inc. NASDAQ:LITE which all got a breakout pattern emerging.

Date Company Price Week 44
Oct 22, 2021 Signet Jewelers Limited $90.07 $89.18 -0.99%
Oct 22, 2021 Veoneer Inc. $35.23 $35.20 -0.0852%
Oct 22, 2021 Sutro Biopharma Inc. $19.01 $20.16 6.05%
Oct 22, 2021 Telos Corp $26.65 $25.91 -2.78%
Oct 22, 2021 Lumentum Holdings Inc. $84.05 $82.58 -1.75%

Signet Jewelers Limited

NYSE:SIG Strong Buy Candidate Score: 5.51
Strong Buy Candidate Score: 5.51 Oct 22, 2021

Signet JewelersThe Signet Jewelers stock price gained 0.301% on the last trading day (Friday, 22nd Oct 2021), rising from $89.80 to $90.07. During the last trading day the stock fluctuated 2.56% from a day low at $88.27 to a day high of $90.53. The price has risen in 6 of the last 10 days and is up by 5.35% over the past 2 weeks. Volume fell on the last day by -186 thousand shares and in total, 445 thousand shares were bought and sold for approximately $40.06 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Apr 04, 2024, it was reported that Telsey Advisory gave SIG a "Market Perform" grade with a "hold" action.

Signet Jewelers holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Signet Jewelers Limited:
Signet Jewelers Limited operates as a diamond jewelry retailer. It operates through three segments: North America, International, and Other. The North America segment operates jewelry stores in jewelry stores in malls, mall-based kiosks, and off-mall locations in the United States and Canada primarily under the Kay Jewelers, Kay Jewelers Outlet, Jared The Galleria Of Jewelry, Jared Vault, Zales Jewelers, Zales Outlet, Diamonds Direct, James Allen, Banter by Piercing Pagoda, and Peoples Jewellers names, as well as operates online through JamesAllen.com and Rocksbox. The International segment operates stores in shopping malls and off-mall locations primarily under the H.Samuel and Ernest Jones brands in the United Kingdom, Republic of Ireland, and Channel Islands. The Other segment is involved in the purchase and conversion of rough diamonds to polished stones, as well as the provision of diamond polishing services. As of January 29, 2022, it operated 2,854 stores and kiosks. Signet Jewelers Limited is based in Hamilton, Bermuda.

Veoneer Inc.

NYSE:VNE Buy Candidate Score: 4.78
Buy Candidate Score: 4.78 Oct 22, 2021

Veoneer Inc.The Veoneer Inc. stock price fell by -0.198% on the last day (Friday, 22nd Oct 2021) from $35.30 to $35.23. During the last trading day the stock fluctuated 0.384% from a day low at $35.17 to a day high of $35.31. The price has fallen in 5 of the last 10 days and is down by -1.59% for this period. Volume has increased on the last day by 333 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 659 thousand shares were bought and sold for approximately $23.22 million.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Veoneer Inc. stock to perform well in the short-term.

Sutro Biopharma Inc.

NASDAQ:STRO Buy Candidate Score: 2.34
Buy Candidate Score: 2.34 Oct 22, 2021

Sutro Biopharma Inc.The Sutro Biopharma Inc. stock price gained 1.39% on the last trading day (Friday, 22nd Oct 2021), rising from $18.75 to $19.01. During the last trading day the stock fluctuated 4.85% from a day low at $18.27 to a day high of $19.15. The price has risen in 6 of the last 10 days and is up by 2.2% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 34 thousand more shares were traded than the day before. In total, 164 thousand shares were bought and sold for approximately $3.11 million.

On Apr 03, 2024, it was reported that Oppenheimer gave STRO a "Outperform" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Sutro Biopharma Inc. stock to perform well in the short-term.

About Sutro Biopharma Inc.:
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Telos Corp

NASDAQ:TLS Buy Candidate Score: 1.96
Buy Candidate Score: 1.96 Oct 22, 2021

Telos CorpThe Telos Corp stock price fell by -1.81% on the last day (Friday, 22nd Oct 2021) from $27.14 to $26.65. During the last trading day the stock fluctuated 3.39% from a day low at $26.57 to a day high of $27.47. The price has risen in 6 of the last 10 days and is up by 0.19% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -597 thousand shares and in total, 325 thousand shares were bought and sold for approximately $8.65 million.

On Nov 10, 2023, it was reported that B. Riley Securities gave TLS a "Buy" grade with a "upgrade" action.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Telos Corp stock to perform well in the short-term period.

About Telos Corp:
Telos Corporation, together with its subsidiaries, provides information technology (IT) solutions and services worldwide. It provides Xacta, a premier platform for enterprise cyber risk management and security compliance automation solutions to large commercial and government enterprises; and Telos Ghost, a solution to eliminate cyber-attack surfaces by obfuscating and encrypting data, masking user identity and location, and hiding network resources, as well as provides security and privacy for intelligence gathering, cyber threat protection, securing critical infrastructure, and protecting communications and applications. The company also offers Telos Automated Message Handling System, a web-based organizational message distribution and management platform for mission-critical communications used by military field operatives; and Telos ID that provides identity trust and digital services through IDTrust360, an enterprise-class digital identity risk platform for extending cloud identity services for mobile and enterprise and custom digital identity services that reduces threats through the integration of advanced technologies that fuse biometrics, credentials, and other identity-centric data used for continuously monitor trust. In addition, it provides secure network services, including secure mobility solutions for business and government that enable remote work and minimize operational and security concern across and beyond the enterprises; and network management and defense services for operating, administrating, and defending complex enterprise networks and defensive cyber operations. It serves to the United States federal government, large commercial businesses, state and local governments, and international customers. The company was founded in 1968 and is headquartered in Ashburn, Virginia.

Lumentum Holdings Inc.

NASDAQ:LITE Buy Candidate Score: 1.66
Buy Candidate Score: 1.66 Oct 22, 2021

Lumentum Holdings Inc.The Lumentum Holdings Inc. stock price fell by -0.98% on the last day (Friday, 22nd Oct 2021) from $84.88 to $84.05. During the last trading day the stock fluctuated 2.27% from a day low at $83.80 to a day high of $85.70. The price has been going up and down for this period, and there has been a -0.13% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -93 thousand shares and in total, 212 thousand shares were bought and sold for approximately $17.79 million.

On Apr 01, 2024, it was reported that Susquehanna gave LITE a "Buy" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lumentum Holdings Inc. stock to perform well in the short-term.

About Lumentum Holdings Inc.:
Lumentum Holdings Inc. manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company operates in two segments, Optical Communications (OpComms) and Commercial Lasers (Lasers). The OpComms segment offers components, modules, and subsystems that enable the transmission and transport of video, audio, and data over high-capacity fiber optic cables. It offers tunable transponders, transceivers, and transmitter modules; tunable lasers, receivers, and modulators; transport products, such as reconfigurable optical add/drop multiplexers, amplifiers, and optical channel monitors, as well as components, including 980nm, multi-mode, and Raman pumps; and switches, attenuators, photodetectors, gain flattening filters, isolators, wavelength-division multiplexing filters, arrayed waveguide gratings, multiplex/de-multiplexers, and integrated passive modules. This segment also provides Super Transport Blade, which integrates optical transport functions into a single-slot blade; vertical-cavity surface-emitting lasers; directly modulated and electro-absorption modulated lasers; and laser illumination sources for 3D sensing systems. It serves customers in telecommunications, data communications, and consumer and industrial markets. The Commercial Lasers segment offers diode-pumped solid-state, fiber, diode, direct-diode, and gas lasers for use in original equipment manufacturer applications. It serves customers in markets and applications, such as sheet metal processing, general manufacturing, biotechnology, graphics and imaging, remote sensing, and precision machining. Lumentum Holdings Inc. was incorporated in 2015 and is headquartered in San Jose, California.

.

StockInvest.usStock Podcast